RSV Prevention in Latin America and the Caribbean: Proven Immediate Benefits and Potential Life-Course Value
Year: 2026
Type: article
Abstract: Respiratory syncytial virus (RSV) remains a leading cause of infant lower respiratory tract infection, hospitalization, and death in Latin America and the Caribbean, where unequal access to diagnosis, medical care, oxygen, referral, and intensive care worsens outcomes. New passive immunization tools, maternal RSV prefusion F vaccination and long-acting monoclonal antibodies, can protect infants before peak vulnerability. Still, their population impact depends on timing, coverage, equity, financing, surveillance, and program design. Emerging regional experience with hybrid strategies may help close protection gaps among infants missed or insufficiently protected by maternal immunization. Severe early-life RSV disease is consistently associated with recurrent lower respiratory tract infections, wheezing, asthma, impaired lung-function trajectories, and increased health-care use. However, causality and long-term effects of current preventive products remain uncertain. A regional agenda linking maternal–infant cohorts, surveillance, equity analyses, and long-term health-economic evaluations is needed to define both the established immediate and potential longer-term public-health value of RSV prevention.
Source: Vaccines
Authors: Roberto Debbag, María L. Ávila-Agüero, José Brea, Renato de Ávila Kfouri, Flor M. Muñoz, Paula Couto, Gonzalo Pérez Marc, Eva María Ruiz de Castilla, Carlos N. Torres-Martinez, Ivan F. Gutierrez-Tobar, Claudia Beltran-Arroyave, Andrés Felipe Arias, Irene Benítez, J. Esteban Bonilla, Vanesa Castellano, Lourdes Dueñas, Dora Estripeaut, Valentina Gutiérrez, Lesly Jacinto, María del Valle Juárez, Gustavo Lazo, Maurice Mayrides, Melissa Palmieri, Andrea Parra-Buitrago, Mónica Pujadas, Jesús Moisés Ramírez, Solana Rapaport, Gabriela Zambrano, Alfonso J. Rodríguez-Morales
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,258
OpenAlex ID: W7213548132
